Literature DB >> 4834890

Elevation of plasma neurophysin in women on oral contraceptives.

A G Robinson.   

Abstract

The effect of oral contraceptives on the neurohypophysis was demonstrated by changes in the plasma level of a posterior pituitary protein. neurophysin. Neurophysins are intraneuronal proteins associated with oxytocin and vasopressin. They have been shown to be released into the bloodstream. The resting plasma level of neurophysin in normal nonpregnant women is 0.69 ng/ml+/-0.7 SD. In women on oral contraceptives, the plasma level is 6.4 ng/ml+/-4.2 SD (P<0.001). Estrogen rather than progesterone causes the elevated neurophysin. The effect is observed within 12-24 h of estrogen administration and disappears 3-11 days after estrogen is discontinued. The results indicate that oral contraceptives act on the neurohypophysis and that estrogen is a potent pharmacologic stimulus useful in studying synthesis and release of neurophysin.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4834890      PMCID: PMC301542          DOI: 10.1172/JCI107745

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Effect of diethylstilbestrol on the binding of thyroxine in serum.

Authors:  J T DOWLING; N FREINKEL; S H INGBAR
Journal:  J Clin Endocrinol Metab       Date:  1956-11       Impact factor: 5.958

2.  Structure and function of the median eminence.

Authors:  K M Knigge; D E Scott
Journal:  Am J Anat       Date:  1970-10

Review 3.  Medical aspects of oral contraceptives.

Authors:  N J Elgee
Journal:  Ann Intern Med       Date:  1970-03       Impact factor: 25.391

Review 4.  Biosynthesis and release of vasopressin and neurophysin.

Authors:  H Sachs; P Fawcett; Y Takabatake; R Portanova
Journal:  Recent Prog Horm Res       Date:  1969

5.  Human neurophysine blood levels under normal, experimental and pathological conditions.

Authors:  J J Legros; P Franchimont
Journal:  Clin Endocrinol (Oxf)       Date:  1972-01       Impact factor: 3.478

6.  Studies of human neurophysin by radioimmunoassay.

Authors:  K W Cheng; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

7.  A system linking the third ventricle with the pars tuberalis of the rhesus monkey.

Authors:  T C Kumar; F Knowles
Journal:  Nature       Date:  1967-07-01       Impact factor: 49.962

8.  Physiologic investigation of posterior pituitary binding proteins neurophysin I and neurophysin II.

Authors:  A G Robinson; E A Zimmerman; A G Frantz
Journal:  Metabolism       Date:  1971-12       Impact factor: 8.694

9.  Vasopressin and neurophysin: high concentrations in monkey hypophyseal portal blood.

Authors:  E A Zimmerman; P W Carmel; M K Husain; M Ferin; M Tannenbaum; A G Frantz; A G Robinson
Journal:  Science       Date:  1973-11-20       Impact factor: 47.728

10.  Cerebrospinal fluid and ependymal neurophysin.

Authors:  A G Robinson; E A Zimmerman
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

View more
  4 in total

1.  Isolation, assay, and secretion of individual human neurophysins.

Authors:  A G Robinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

Review 2.  Transgenic and transcriptional studies on neurosecretory cell gene expression.

Authors:  S J Waller; A Ratty; J P Burbach; D Murphy
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

3.  Presence of neurophysin and vasopressin in the hypothalamic magnocellular nuclei of rats homozygous and heterozygous for diabetes insipidus (Brattleboro strain) as revealed by immunoperoxidase history.

Authors:  W B Watkins
Journal:  Cell Tissue Res       Date:  1975       Impact factor: 5.249

4.  Changes in oxytocin content in the magnocellular neurons of the rat hypothalamus following water deprivation or estrogen treatment. Quantitative immunohistological studies.

Authors:  C H Rhodes; J I Morrell; D W Pfaff
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.